DELAYED GRAFT FUNCTION
Clinical trials for DELAYED GRAFT FUNCTION explained in plain language.
Never miss a new study
Get alerted when new DELAYED GRAFT FUNCTION trials appear
Sign up with your email to follow new studies for DELAYED GRAFT FUNCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a 2-Day infusion save transplanted kidneys?
Disease control Recruiting nowThis study tests if a drug called treprostinil can help protect a new kidney from injury during transplant surgery. About 20 adults receiving a deceased donor kidney will get the drug through an IV for two days. The goal is to see if it improves kidney function and reduces the ne…
Matched conditions: DELAYED GRAFT FUNCTION
Phase: PHASE1, PHASE2 • Sponsor: Rhode Island Hospital • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New drug aims to cut dialysis time after kidney transplant
Disease control Recruiting nowThis study tests if the drug ravulizumab can help transplanted kidneys start working sooner, reducing the need for dialysis. It involves 450 adults at high risk for delayed graft function after receiving a deceased donor kidney. Participants will receive either ravulizumab or a p…
Matched conditions: DELAYED GRAFT FUNCTION
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
Could a common acid reflux drug protect new kidneys?
Disease control Recruiting nowThis study tests whether a medicine called vonoprazan fumarate, usually used for stomach acid, can help prevent delayed kidney function after a deceased-donor kidney transplant. About 47 first-time kidney transplant recipients will take the drug daily for a week after surgery. Th…
Matched conditions: DELAYED GRAFT FUNCTION
Phase: PHASE1, PHASE2 • Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
New drug aims to jumpstart transplanted kidneys faster
Disease control Recruiting nowThis study tests a drug called pegcetacoplan in 320 adults who are getting a kidney transplant from a deceased donor and are at high risk for delayed graft function (when the kidney takes a while to start working). Participants receive either the drug or a placebo after surgery. …
Matched conditions: DELAYED GRAFT FUNCTION
Phase: PHASE3 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC